| abstract |
An objective of the present invention is to provide a new class of compounds that have HSP90 inhibitory activity and are useful as anticancer agents and such, and to provide compounds that are useful as their synthetic intermediates. The above-described objective is accomplished by providing compounds represented by formula (1) shown below, pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising such compounds. |